Genetic Counseling for Fragile X Syndrome: Updated Recommendations of the National Society of Genetic Counselors |
| |
Authors: | Email author" target="_blank">Allyn?McConkie-RosellEmail author Brenda?Finucane Amy?Cronister Liane?Abrams Robin?L?Bennett Barbara?J?Pettersen |
| |
Institution: | (1) Duke University Medical Center, Durham, North Carolina;(2) Elwyn Training and Research Institute, Elwyn, Pennsylvania;(3) Genzyme Genetics, Phoenix, Arizona;(4) Liane Abrams: National Fragile X Foundation, San Francisco, CA;(5) Medical Genetics, Department of Medicine, University of Washington, Seattle, Washington;(6) Genetic Counseling of Central Oregon, Bend, Oregon;(7) Division of Medical Genetics, Duke University Medical Center, Box 3525, Durham, North Carolina, 27710 |
| |
Abstract: | These recommendations describe the minimum standard criteria for genetic counseling and testing of individuals and families
with fragile X syndrome, as well as carriers and potential carriers of a fragile X mutation. The original guidelines (published
in 2000) have been revised, replacing a stratified pre- and full mutation model of fragile X syndrome with one based on a
continuum of gene effects across the full spectrum of FMR1 CGG trinucleotide repeat expansion. This document reviews the molecular
genetics of fragile X syndrome, clinical phenotype (including the spectrum of premature ovarian failure and fragile X-associated
tremor-ataxia syndrome), indications for genetic testing and interpretation of results, risks of transmission, family planning
options, psychosocial issues, and references for professional and patient resources. These recommendations are the opinions
of a multicenter working group of genetic counselors with expertise in fragile X syndrome genetic counseling, and they are
based on clinical experience, review of pertinent English language articles, and reports of expert committees. These recommendations
should not be construed as dictating an exclusive course of management, nor does use of such recommendations guarantee a particular
outcome. The professional judgment of a health care provider, familiar with the facts and circumstances of a specific case,
will always supersede these recommendations. |
| |
Keywords: | fragile X syndrome genetic counseling genetic testing premature ovarian failure FXTAS premutation FMR1 prenatal diagnosis National Society of Genetic Counselors practice guidelines |
本文献已被 PubMed SpringerLink 等数据库收录! |
|